Earnings Preview | Q2 2026 | Earnings Date: July 24, 2026 | Prepared: July 22, 2026
Key Takeaway: Setup is mixed-to-slightly-cautious — consensus has been trimmed since the Q1 miss and the bar is now more achievable, but the single biggest swing factor is whether Group Benefits disability loss ratios stabilize after the Q1 deterioration, with Business Insurance written premium growth and NII as secondary swing factors.
Heading into the Q2 2026 print, the consensus bar has been reset lower following HIG's Q1 miss, with operating EPS consensus at $3.10 versus the $2.91 Q1 actual — a more achievable hurdle given the seasonal tailwinds that typically benefit Q2. Management's tone on the Q1 call was constructive: CEO Chris Swift described results as "strong, building on continued momentum," reaffirmed expense ratio improvement targets through 2027, and guided for $450M in Q2 share repurchases — all signals of confidence. Estimate revisions have been modestly negative since the Q1 print (Q2 EPS consensus slipped from $3.30 to $3.10), reflecting lingering concern about Group Benefits disability trends and LP income volatility, but the gap is not wide enough to represent a structural miss risk. The stock has underperformed both the insurance ETF (KIE, +7.7%) and the S&P 500 (+5.5%) since the Q1 earnings date, trading down roughly 1% on an indexed basis, suggesting the market has not priced in a beat and sentiment remains cautious. The key wildcard is catastrophe losses: Q1 cats ran ~$30M above expectations, and with the aggregate reinsurance treaty at $204M of a $750M threshold through Q1, any elevated Q2 cat activity could pressure the combined ratio and overshadow otherwise solid underwriting results.
Key Takeaway: Consensus is a moderate bar after Q1 reset — Business Insurance written premium growth (~$4.0B, +5.8% YoY) and the underlying combined ratio (~88.4%) are the primary swing factors, while Group Benefits margin recovery from Q1's 6.9% is the key watch item for sentiment.
KPI | Q1 2026 Actual (Last Quarter) | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance | Consensus vs. Guidance |
Operating EPS ($) | $2.91 | $3.41 | $3.10 | -9.1% | No specific Q2 guidance | N/A |
Written Premium — Business Insurance ($B) | $3.90B | $3.82B | $4.02B | +5.8% | ~10% property premium growth for FY2026; pricing ex-WC ~6% | Tracking above implied run-rate |
Written Premium — Personal Lines ($B) | $0.86B | $0.98B | $0.95B | -3.1% | Prevail rollout to 30 states by early 2027; growth pivot underway | N/A — no specific premium guidance |
Underlying Combined Ratio — Business Insurance (%) | 89.2% | 88.0% | 88.4% | +0.4 pts | Expense ratio target below 30% by end of 2027 | N/A — no specific UCR guidance |
Underlying Combined Ratio — Personal Lines (%) | 85.0% | 88.0% | 86.5% | -1.5 pts | PI expense ratio target below 25% by end of 2027 | N/A — no specific UCR guidance |
Net Investment Income ($M) | $734M | $658M | $729M | +10.8% | FY2026 NII to increase vs. 2025; portfolio yields generally in line with 2025 | Slightly below FY implied run-rate ($3.02B / 4 = ~$755M) |
Core Earnings Margin — Group Benefits (%) | 6.9% | 9.2% | 8.1% | -1.1 pts | EB expense ratio target ~25% by end of 2027 | N/A — no specific margin guidance |
Earned Premiums — Group Benefits ($B) | $1.67B | $1.61B | $1.64B | +1.9% | Strong sales growth (+53% in Q1); persistency in low 90s | N/A |
Source: Visible Alpha Consensus and Actuals Data. All consensus figures as of July 22, 2026.
Top KPI 1: Operating EPS ($) | Top KPI 2: Written Premium — Business Insurance ($B)
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Operating EPS | $2.91 | $3.38 | -13.9% | MISS |
Q1 2026 | BI Written Premium | $3.90B | $3.91B | -0.2% | IN LINE |
Q4 2025 | Operating EPS | $4.06 | $3.21 | +26.5% | BEAT |
Q4 2025 | BI Written Premium | $3.38B | $3.41B | -0.9% | IN LINE |
Q3 2025 | Operating EPS | $3.78 | $3.27 | +15.6% | BEAT |
Q3 2025 | BI Written Premium | $3.57B | $3.52B | +1.4% | BEAT |
Q2 2025 | Operating EPS | $3.41 | $2.84 | +20.1% | BEAT |
Q2 2025 | BI Written Premium | $3.82B | $3.83B | -0.3% | IN LINE |
Q1 2025 | Operating EPS | $2.20 | $2.15 | +2.3% | BEAT |
Q1 2025 | BI Written Premium | $3.69B | $3.62B | +1.9% | BEAT |
Q4 2024 | Operating EPS | $2.94 | $2.67 | +10.1% | BEAT |
Q4 2024 | BI Written Premium | $3.17B | $3.25B | -2.5% | MISS |
Q3 2024 | Operating EPS | $2.53 | $2.57 | -1.6% | IN LINE |
Q3 2024 | BI Written Premium | $3.28B | $3.28B | -0.2% | IN LINE |
Q2 2024 | Operating EPS | $2.50 | $2.27 | +10.1% | BEAT |
Q2 2024 | BI Written Premium | $3.54B | $3.43B | +3.2% | BEAT |
Pattern: HIG has beaten Operating EPS consensus in 6 of the last 8 quarters, with the sole miss being Q1 2026 (driven by a legacy GL reserve charge and elevated disability loss ratios). Business Insurance written premium has been consistently in-line to slightly above consensus, reflecting disciplined underwriting rather than volume surprises. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance is largely unchanged since the Q1 2026 earnings call (April 23–24, 2026) — management reaffirmed all key targets and the only post-earnings development was a routine board appointment. Tone remains constructive on Business Insurance and Personal Lines, with the primary watch item being Group Benefits disability trends and LP income volatility.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 23–24) | Revised Guidance | Current Consensus | Note |
Net Investment Income (FY2026) | Increase vs. 2025; portfolio yields generally in line with 2025 | — | $3.02B (FY2026) | Unchanged. Geopolitical volatility flagged as near-term LP headwind. |
Share Repurchases (Q2 2026) | $450M in Q2 (same pace as Q1); $1.1B remaining authorization through Dec 31, 2026 | — | N/A (not a consensus KPI) | Unchanged. Explicit Q2 buyback guidance is a positive capital return signal. |
Business Insurance Expense Ratio | Below 30% by end of 2027; decline in 2026 vs. 2025 (from 31.6% in Q1 2026) | — | 88.4% UCR consensus (Q2 2026) | Unchanged. Management reaffirmed all 2027 targets explicitly on Q1 call. |
Personal Lines Expense Ratio | Below 25% by end of 2027; Prevail Agency live in 15 states, 30 states by early 2027 | — | 86.5% UCR consensus (Q2 2026) | Unchanged. Prevail rollout on track; growth pivot underway. |
Employee Benefits Expense Ratio | ~25% by end of 2027; disability loss ratio expected to moderate through 2026 | — | 8.1% core earnings margin consensus (Q2 2026) | Unchanged. Paid Family Leave new state pent-up demand expected to moderate. |
Property Premium Growth (FY2026) | ~10% growth on $3.3B 2025 base (~$3.6B target); good margins and returns | — | N/A (not separately tracked in VA) | Unchanged. Differentiated from large account/E&S property softening. |
Catastrophe Aggregate Treaty | $204M of $750M threshold reached through Q1 2026; treaty kicks in at $750M | — | N/A | Key watch item: Q2 cat activity will determine proximity to treaty attachment. |
Key Takeaway: Q2 2026 Operating EPS estimates have been revised down ~6% since the Q1 print (from $3.30 to $3.10), while FY2026 EPS has been trimmed modestly from $13.09 to $12.40 — revisions are tracking guidance directionally but the gap between current consensus and the implied FY run-rate suggests the Street is embedding some conservatism on Group Benefits and LP income.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (Apr 28, 2026) | Current Consensus (Jul 22, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Operating EPS — Q2 2026 | $3.30 | $3.10 | -6.1% | No specific Q2 EPS guidance | Unchanged | — | N/A |
Operating EPS — FY2026 | $13.09 | $12.40 | -5.3% | No specific FY EPS guidance | Unchanged | — | N/A |
BI Written Premium — Q2 2026 | $4.03B | $4.02B | -0.2% | ~10% property growth; pricing ex-WC ~6% | Unchanged | — | Tracking in line |
BI Written Premium — FY2026 | $15.27B | $15.25B | -0.1% | ~10% property growth; pricing ex-WC ~6% | Unchanged | — | Tracking in line |
Net Investment Income — Q2 2026 | $741M | $729M | -1.6% | FY2026 NII to increase vs. 2025 | Unchanged | — | Slightly below FY implied run-rate |
Net Investment Income — FY2026 | $3.03B | $3.02B | -0.5% | FY2026 NII to increase vs. 2025 | Unchanged | — | Tracking guidance |
BI Underlying Combined Ratio — Q2 2026 | 88.4% | 88.4% | 0.0% | Expense ratio below 30% by end of 2027 | Unchanged | — | Stable; no revision |
Group Benefits Core Earnings Margin — Q2 2026 | 8.3% | 8.1% | -2.4% | EB expense ratio ~25% by end of 2027; disability to moderate | Unchanged | — | Slight downward drift; disability uncertainty |
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline as of April 28, 2026 (5 trading days after April 23, 2026 earnings release). Current consensus as of July 22, 2026.
The ~6% downward revision to Q2 and FY2026 EPS since the Q1 print is almost entirely attributable to the Group Benefits disability surprise and LP income uncertainty flagged by management. Business Insurance premium and combined ratio estimates have been remarkably stable, suggesting the Street has high conviction in the underwriting franchise but is embedding a margin-of-safety discount on the more volatile earnings lines.
Key Takeaway: HIG has meaningfully underperformed both the insurance sector (KIE: +7.7%) and the S&P 500 (SPY: +5.5%) since the Q1 2026 earnings date, with the stock essentially flat (+0.9% indexed) — the underperformance is sentiment-driven following the Q1 EPS miss and disability surprise, not multiple compression, as the broader insurance sector has re-rated higher.
HIG vs. KIE (Insurance ETF) vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (April 23, 2026). KIE is the SPDR S&P Insurance ETF, the most appropriate sector benchmark for HIG's P&C and benefits business mix. Source: Stock Price Data.
HIG opened the post-Q1 period at $139.61 and traded as low as $125.94 (June 3) before recovering to $140.84 as of July 22, 2026. The stock's trajectory tells a clear story: an immediate ~4% drop on the Q1 miss (April 24), followed by continued drift lower through late May/early June as disability concerns lingered, then a recovery in July as the insurance sector broadly re-rated on strong peer prints from TRV and CB. The recovery has been driven by sector rotation and peer read-through rather than HIG-specific catalysts, leaving the stock essentially flat on an absolute basis while peers have outperformed.
Sector ETF: KIE (SPDR S&P Insurance ETF) — appropriate benchmark given HIG's primary exposure to P&C insurance and group benefits. KIE's +7.7% outperformance vs. HIG's flat return since Q1 earnings reflects the market's preference for peers with cleaner earnings quality and no disability overhang.
Key Takeaway: Q2 2026 peer prints from Travelers (TRV) and Chubb (CB) are strongly positive read-throughs for HIG's Business Insurance segment — record underwriting results, disciplined pricing, and favorable reserve development signal a healthy commercial P&C environment. The key negative read-through is from CNA (Q1) and CB (Q2) on casualty loss cost inflation remaining elevated (6–12% annually), which is directly relevant to HIG's GL and excess casualty reserves. Group Benefits disability trends from MET (Q1) provide a mixed read-through: elevated new-state PFL claims are expected to moderate in H2, which is constructive for HIG's Q2 outlook.
Note: Only peer commentary about Q2 2026 (current reporting quarter) or forward-looking commentary made after Q1 2026 earnings is included below. Q1 2026 results commentary from peers is excluded.
Read-Through: STRONGLY POSITIVE for HIG Business Insurance
Read-Through: MIXED — Positive on underwriting results; cautionary on casualty loss cost inflation
Read-Through: MIXED — Constructive on casualty; cautionary on property and MGU model risks
Read-Through: CAUTIONARY on casualty loss trends; relevant to HIG's GL and excess casualty reserves
Read-Through: MIXED — Positive on casualty pricing; cautionary on property and LP income
Read-Through: CONSTRUCTIVE for HIG Group Benefits H2 2026 outlook
Peer | Report Date | HIG Segment | Read-Through Signal | Key Implication for HIG Q2 |
TRV | Jul 17, 2026 (Q2) | Business Insurance | Strongly Positive | Record BI UCR 88.2%; favorable WC/property reserves; pricing discipline holding |
CB | Jul 22, 2026 (Q2) | Business Insurance / GL Reserves | Mixed | Strong underwriting; but casualty loss costs 6–12% annually with zero abatement |
WRB | Jul 20, 2026 (Q2) | Business Insurance / Property | Mixed | Casualty attractive; property eroding rapidly; MGA model risk building |
CNA | May 3, 2026 (Q1) | GL / Excess Casualty Reserves | Cautionary | Social inflation not abating; excess casualty reserve strengthening; loss cost trends >7% |
AIG | May 1, 2026 (Q1) | Business Insurance / NII | Mixed | Casualty pricing adequate; LP income headwind in Q2; E&S property contracting |
MET | May 7, 2026 (Q1) | Group Benefits / Disability | Constructive | New-state PFL claims to moderate in H2; LTD severity not a trend; strong sales |
Key Takeaway: The most material post-Q1 development is the strong peer read-throughs from TRV and CB Q2 prints (both reported this week), which confirm a healthy commercial P&C underwriting environment heading into HIG's July 24 print. The only company-specific news was a routine board appointment.
Key Takeaway: No open-market buys or discretionary sells since the Q1 earnings date. The two transactions on record are a 10b5-1 plan exercise (President Tooker) and a tax withholding share surrender (CIO Pannala) — neither is a meaningful signal; insider activity is effectively silent heading into Q2 earnings.
Name | Title | Transaction Type | Shares | Date | Note |
Adin M. Tooker | President | 10b5-1 Plan Exercise (Acquisition via Option/Award) | 8,895 shares | May 27, 2026 | Form 4 code M (exercise of derivative security under pre-established 10b5-1 plan). Not a discretionary open-market buy. Routine compensation-related transaction. |
Shekar Pannala | EVP & Chief Information Officer | Tax Withholding Share Surrender (Disposition) | 7,074 shares | May 4, 2026 | Form 4 code F (shares withheld for tax obligation on vesting). Not a discretionary open-market sale. Routine tax withholding on equity award vesting. |
Source: Insider Transaction Data (SEC Form 4 filings). Transactions shown are from the post-Q1 2026 earnings window (April 23, 2026 – July 22, 2026). No open-market buys (Form 4 code P) or discretionary open-market sales (Form 4 code S) were filed during this period. The absence of insider buying ahead of earnings is not unusual for a large-cap insurer with active 10b5-1 programs, but the lack of any discretionary selling is a mild positive signal.